354 related articles for article (PubMed ID: 12698075)
21. Prevention of graft-versus-host disease in rat small bowel transplantation by recipient pretreatment with UV-B-modulated bone marrow cells.
Chowdhury NC; Jin MX; Oluwole SF
Transplantation; 1993 Jun; 55(6):1229-35. PubMed ID: 8516807
[TBL] [Abstract][Full Text] [Related]
22. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
Gammie JS; Li S; Colson YL; Demetris AJ; Neipp M; Ildstad ST; Pham SM
Exp Hematol; 1998 Sep; 26(10):927-35. PubMed ID: 9728927
[TBL] [Abstract][Full Text] [Related]
23. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
Masaki H; Appel MC; Leahy L; Leif J; Paquin L; Shultz LD; Mordes JP; Greiner DL; Rossini AA
Xenotransplantation; 2006 May; 13(3):224-32. PubMed ID: 16756565
[TBL] [Abstract][Full Text] [Related]
24. Mixed xenogeneic chimerism and tolerance III. A nonlethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts.
Li H; Abou el-Ezz AY; Gambrell BE; Ildstad ST
Transplantation; 1995 Jul; 60(1):59-65. PubMed ID: 7624944
[TBL] [Abstract][Full Text] [Related]
25. The role of cyclophosphamide and granulocyte colony-stimulation factor in achieving high-level chimerism in allotransplanted limbs.
Muramatsu K; You-Xin S; Hashimoto T; Matsunaga T; Taguchi T
J Orthop Res; 2006 Nov; 24(11):2133-40. PubMed ID: 16944471
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
27. Donor-specific tolerance induction in composite tissue allografts.
Foster RD; Fan L; Neipp M; Kaufman C; McCalmont T; Ascher N; Ildstad S; Anthony JP; Niepp M
Am J Surg; 1998 Nov; 176(5):418-21. PubMed ID: 9874425
[TBL] [Abstract][Full Text] [Related]
28. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
29. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras.
Morrissey NJ; Blom D; Ryan CK; Fisher T; Bronsther O; Orloff MS
Transpl Immunol; 1999 Mar; 7(1):19-25. PubMed ID: 10375074
[TBL] [Abstract][Full Text] [Related]
30. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
31. A modified model of hindlimb osteomyocutaneous flap for the study of tolerance to composite tissue allografts.
Adamson LA; Huang WC; Breidenbach WC; Rahhal D; Xu H; Huang Y; Pidwell DJ; Wei FC; Tobin G; Ildstad ST
Microsurgery; 2007; 27(7):630-6. PubMed ID: 17868137
[TBL] [Abstract][Full Text] [Related]
32. [Adenovirus-mediated CTLA4 immunoglobulin based conditioning for non-myeloablative allogeneic hematopoietic cell transplantation to induce tolerance to hind limb allografts in rats].
Pan H; Wang L; Zhang XD; Mai HX; Liu D; Liu Y; Guo SZ
Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(12):937-40. PubMed ID: 19781252
[TBL] [Abstract][Full Text] [Related]
33. Regulation of donor T cells in the tolerant rats to graft-versus-host disease by FTY720 following small bowel transplantation.
Song J; Ito T; Matsuda C; Tanemura M; Nishida T; Nozawa M; Sawa Y
Transplant Proc; 2006 Dec; 38(10):3181-3. PubMed ID: 17175216
[TBL] [Abstract][Full Text] [Related]
34. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
35. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
[TBL] [Abstract][Full Text] [Related]
36. Myeloablative irradiation, granulocyte-colony stimulating factor, and FK506 can induce macrochimerism and prolong the survival of experimental extremity allografts.
Muramatsu K; Kato H; Yoshida Y; Moriya A; Okimoto T; Taguchi T
J Surg Res; 2011 Dec; 171(2):807-13. PubMed ID: 20538288
[TBL] [Abstract][Full Text] [Related]
37. Induction of specific tolerance to small-bowel allografts.
Orloff MS; Fallon MA; DeMara E; Coppage ML; Leong N; Cerilli J
Surgery; 1994 Aug; 116(2):222-8. PubMed ID: 8047988
[TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
Brok HP; Vossen JM; Heidt PJ
Bone Marrow Transplant; 1997 Mar; 19(6):601-6. PubMed ID: 9085739
[TBL] [Abstract][Full Text] [Related]
39. [Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)].
Weigao C
Fukuoka Igaku Zasshi; 1996 Sep; 87(9):197-205. PubMed ID: 8913057
[TBL] [Abstract][Full Text] [Related]
40. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
Prigozhina TB; Elkin G; Khitrin S; Slavin S
Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
